サマリー

タンパク質治療薬の世界市場 2023-2027
Technavioは、タンパク質治療薬市場をモニターしており、2022年から2027年の間に1535億6000万ドル、予測期間中のCAGRは9.14%で加速して成長すると予測しています。当レポートでは、タンパク質治療薬市場について、全体的な分析、市場規模と予測、トレンド、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、mAbの需要の増加、革新的な技術を用いた新規治療法の開発、有利な償還政策の利用可能性によって牽引されています。
Technavioのタンパク質治療薬市場は以下のようにセグメント化されています：
製品別
- mAbs
- ヒトインスリン
- エリスロポエチン
- 凝固因子
- その他
アプリケーション別
- メタボリックシンドローム
- 免疫学的疾患
- 血液疾患
- がん（Cancer
- 遺伝性疾患
地理的景観別
- 北アメリカ
- ヨーロッパ
- 亜細亜
- レスト・オブ・ワールド（ROW）
本調査では、今後数年間におけるタンパク質治療薬市場の成長を促進する主な理由の一つとして、製品の改良に重点を置いていることを挙げています。また、オンライン販売の出現と慢性疾患の増加は、市場の大きな需要につながるでしょう。
Technavioは、複数の情報源からのデータを、主要パラメータの分析によって調査、合成、総括する方法で、市場の詳細な姿を提示します。当レポートでは、タンパク質治療薬市場について、以下の分野を取り上げています：
- タンパク質治療薬市場のサイジング
- 蛋白質治療薬市場予測
- タンパク質治療薬市場の産業分析
Technavioの強固なベンダー分析は、クライアントの市場ポジションの向上に役立つように設計されており、これに沿って、本レポートでは、AbbVie Inc.、Amgen Inc.、AstraZeneca Plc、Biocon Ltd. 、Biogen Inc. 、Bristol Myers Squibb Co. 、Celltrion Healthcare Co.Ltd., Creative Biolabs, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Intas Pharmaceuticals Ltd., Ipsen Pharma, Johnson and Johnson Services Inc., LGM Pharma LLC, Midas Pharma GmbH, Novartis AG, Novo Nordisk AS, Pfizer Inc, PV Pharma Healthcare Pvt. Ltd, and Sanofi SA.また、タンパク質治療薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報を客観的に組み合わせて実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/protein-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。また、業界の主要なインフルエンサーを特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global protein therapeutics market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global protein therapeutics market 2017 - 2021 ($ billion)
o 4.2 Product Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
o 4.3 Application Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 mAbs - Market size and forecast 2022-2027
o Exhibit 34: Chart on mAbs - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on mAbs - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on mAbs - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on mAbs - Year-over-year growth 2022-2027 (%)
o 6.4 Human insulin - Market size and forecast 2022-2027
o Exhibit 38: Chart on Human insulin - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Human insulin - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Human insulin - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Human insulin - Year-over-year growth 2022-2027 (%)
o 6.5 Erythropoeitin - Market size and forecast 2022-2027
o Exhibit 42: Chart on Erythropoeitin - Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Erythropoeitin - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Erythropoeitin - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Erythropoeitin - Year-over-year growth 2022-2027 (%)
o 6.6 Clotting factors - Market size and forecast 2022-2027
o Exhibit 46: Chart on Clotting factors - Market size and forecast 2022-2027 ($ billion)
o Exhibit 47: Data Table on Clotting factors - Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Chart on Clotting factors - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Clotting factors - Year-over-year growth 2022-2027 (%)
o 6.7 Others - Market size and forecast 2022-2027
o Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Product
o Exhibit 54: Market opportunity by Product ($ billion)
o Exhibit 55: Data Table on Market opportunity by Product ($ billion)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 56: Chart on Application - Market share 2022-2027 (%)
o Exhibit 57: Data Table on Application - Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 58: Chart on Comparison by Application
o Exhibit 59: Data Table on Comparison by Application
o 7.3 Metabolic disorders - Market size and forecast 2022-2027
o Exhibit 60: Chart on Metabolic disorders - Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Metabolic disorders - Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Metabolic disorders - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Metabolic disorders - Year-over-year growth 2022-2027 (%)
o 7.4 Immunologic disorders - Market size and forecast 2022-2027
o Exhibit 64: Chart on Immunologic disorders - Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Data Table on Immunologic disorders - Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Chart on Immunologic disorders - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Immunologic disorders - Year-over-year growth 2022-2027 (%)
o 7.5 Hematological disorders - Market size and forecast 2022-2027
o Exhibit 68: Chart on Hematological disorders - Market size and forecast 2022-2027 ($ billion)
o Exhibit 69: Data Table on Hematological disorders - Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Chart on Hematological disorders - Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Hematological disorders - Year-over-year growth 2022-2027 (%)
o 7.6 Cancer - Market size and forecast 2022-2027
o Exhibit 72: Chart on Cancer - Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Data Table on Cancer - Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Chart on Cancer - Year-over-year growth 2022-2027 (%)
o Exhibit 75: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
o 7.7 Genetic disorders - Market size and forecast 2022-2027
o Exhibit 76: Chart on Genetic disorders - Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Data Table on Genetic disorders - Market size and forecast 2022-2027 ($ billion)
o Exhibit 78: Chart on Genetic disorders - Year-over-year growth 2022-2027 (%)
o Exhibit 79: Data Table on Genetic disorders - Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Application
o Exhibit 80: Market opportunity by Application ($ billion)
o Exhibit 81: Data Table on Market opportunity by Application ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 83: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 84: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 85: Chart on Geographic comparison
o Exhibit 86: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 87: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 91: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 95: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 99: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 103: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Canada - Market size and forecast 2022-2027
o Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 111: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 112: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 113: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 UK - Market size and forecast 2022-2027
o Exhibit 115: Chart on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 116: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 117: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 118: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 119: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 120: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 121: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 122: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 123: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 125: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 127: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 128: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 129: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 130: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 131: AbbVie Inc. - Overview
o Exhibit 132: AbbVie Inc. - Product / Service
o Exhibit 133: AbbVie Inc. - Key news
o Exhibit 134: AbbVie Inc. - Key offerings
o 12.4 Amgen Inc.
o Exhibit 135: Amgen Inc. - Overview
o Exhibit 136: Amgen Inc. - Product / Service
o Exhibit 137: Amgen Inc. - Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 138: AstraZeneca Plc - Overview
o Exhibit 139: AstraZeneca Plc - Product / Service
o Exhibit 140: AstraZeneca Plc - Key news
o Exhibit 141: AstraZeneca Plc - Key offerings
o 12.6 Biogen Inc.
o Exhibit 142: Biogen Inc. - Overview
o Exhibit 143: Biogen Inc. - Product / Service
o Exhibit 144: Biogen Inc. - Key offerings
o 12.7 Bristol Myers Squibb Co.
o Exhibit 145: Bristol Myers Squibb Co. - Overview
o Exhibit 146: Bristol Myers Squibb Co. - Product / Service
o Exhibit 147: Bristol Myers Squibb Co. - Key news
o Exhibit 148: Bristol Myers Squibb Co. - Key offerings
o 12.8 Creative Biolabs
o Exhibit 149: Creative Biolabs - Overview
o Exhibit 150: Creative Biolabs - Product / Service
o Exhibit 151: Creative Biolabs - Key offerings
o 12.9 Eli Lilly and Co.
o Exhibit 152: Eli Lilly and Co. - Overview
o Exhibit 153: Eli Lilly and Co. - Product / Service
o Exhibit 154: Eli Lilly and Co. - Key offerings
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 155: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 156: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 157: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 158: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 159: F. Hoffmann La Roche Ltd. - Segment focus
o 12.11 Ipsen Pharma
o Exhibit 160: Ipsen Pharma - Overview
o Exhibit 161: Ipsen Pharma - Business segments
o Exhibit 162: Ipsen Pharma - Key offerings
o Exhibit 163: Ipsen Pharma - Segment focus
o 12.12 Johnson and Johnson Services Inc.
o Exhibit 164: Johnson and Johnson Services Inc. - Overview
o Exhibit 165: Johnson and Johnson Services Inc. - Business segments
o Exhibit 166: Johnson and Johnson Services Inc. - Key news
o Exhibit 167: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 168: Johnson and Johnson Services Inc. - Segment focus
o 12.13 LGM Pharma LLC
o Exhibit 169: LGM Pharma LLC - Overview
o Exhibit 170: LGM Pharma LLC - Product / Service
o Exhibit 171: LGM Pharma LLC - Key offerings
o 12.14 Novartis AG
o Exhibit 172: Novartis AG - Overview
o Exhibit 173: Novartis AG - Business segments
o Exhibit 174: Novartis AG - Key offerings
o Exhibit 175: Novartis AG - Segment focus
o 12.15 Novo Nordisk AS
o Exhibit 176: Novo Nordisk AS - Overview
o Exhibit 177: Novo Nordisk AS - Business segments
o Exhibit 178: Novo Nordisk AS - Key offerings
o Exhibit 179: Novo Nordisk AS - Segment focus
o 12.16 Pfizer Inc.
o Exhibit 180: Pfizer Inc. - Overview
o Exhibit 181: Pfizer Inc. - Product / Service
o Exhibit 182: Pfizer Inc. - Key news
o Exhibit 183: Pfizer Inc. - Key offerings
o 12.17 Sanofi SA
o Exhibit 184: Sanofi SA - Overview
o Exhibit 185: Sanofi SA - Business segments
o Exhibit 186: Sanofi SA - Key news
o Exhibit 187: Sanofi SA - Key offerings
o Exhibit 188: Sanofi SA - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 189: Inclusions checklist
o Exhibit 190: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 191: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 192: Research methodology
o Exhibit 193: Validation techniques employed for market sizing
o Exhibit 194: Information sources
o 13.5 List of abbreviations
o Exhibit 195: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global protein therapeutics market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on mAbs - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on mAbs - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on mAbs - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on mAbs - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Human insulin - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Human insulin - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Human insulin - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Human insulin - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Erythropoeitin - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Erythropoeitin - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Erythropoeitin - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Erythropoeitin - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Clotting factors - Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on Clotting factors - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on Clotting factors - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Clotting factors - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Product ($ billion)
Exhibits55: Data Table on Market opportunity by Product ($ billion)
Exhibits56: Chart on Application - Market share 2022-2027 (%)
Exhibits57: Data Table on Application - Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by Application
Exhibits59: Data Table on Comparison by Application
Exhibits60: Chart on Metabolic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Metabolic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Metabolic disorders - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Metabolic disorders - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Immunologic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Immunologic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Immunologic disorders - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Immunologic disorders - Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Hematological disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits69: Data Table on Hematological disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits70: Chart on Hematological disorders - Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Hematological disorders - Year-over-year growth 2022-2027 (%)
Exhibits72: Chart on Cancer - Market size and forecast 2022-2027 ($ billion)
Exhibits73: Data Table on Cancer - Market size and forecast 2022-2027 ($ billion)
Exhibits74: Chart on Cancer - Year-over-year growth 2022-2027 (%)
Exhibits75: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
Exhibits76: Chart on Genetic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Data Table on Genetic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits78: Chart on Genetic disorders - Year-over-year growth 2022-2027 (%)
Exhibits79: Data Table on Genetic disorders - Year-over-year growth 2022-2027 (%)
Exhibits80: Market opportunity by Application ($ billion)
Exhibits81: Data Table on Market opportunity by Application ($ billion)
Exhibits82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits83: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits84: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits85: Chart on Geographic comparison
Exhibits86: Data Table on Geographic comparison
Exhibits87: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits112: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits113: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits115: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits116: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits117: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits118: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits119: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits120: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits121: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits122: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits123: Market opportunity By Geographical Landscape ($ billion)
Exhibits124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits125: Impact of drivers and challenges in 2022 and 2027
Exhibits126: Overview on Criticality of inputs and Factors of differentiation
Exhibits127: Overview on factors of disruption
Exhibits128: Impact of key risks on business
Exhibits129: Vendors covered
Exhibits130: Matrix on vendor position and classification
Exhibits131: AbbVie Inc. - Overview
Exhibits132: AbbVie Inc. - Product / Service
Exhibits133: AbbVie Inc. - Key news
Exhibits134: AbbVie Inc. - Key offerings
Exhibits135: Amgen Inc. - Overview
Exhibits136: Amgen Inc. - Product / Service
Exhibits137: Amgen Inc. - Key offerings
Exhibits138: AstraZeneca Plc - Overview
Exhibits139: AstraZeneca Plc - Product / Service
Exhibits140: AstraZeneca Plc - Key news
Exhibits141: AstraZeneca Plc - Key offerings
Exhibits142: Biogen Inc. - Overview
Exhibits143: Biogen Inc. - Product / Service
Exhibits144: Biogen Inc. - Key offerings
Exhibits145: Bristol Myers Squibb Co. - Overview
Exhibits146: Bristol Myers Squibb Co. - Product / Service
Exhibits147: Bristol Myers Squibb Co. - Key news
Exhibits148: Bristol Myers Squibb Co. - Key offerings
Exhibits149: Creative Biolabs - Overview
Exhibits150: Creative Biolabs - Product / Service
Exhibits151: Creative Biolabs - Key offerings
Exhibits152: Eli Lilly and Co. - Overview
Exhibits153: Eli Lilly and Co. - Product / Service
Exhibits154: Eli Lilly and Co. - Key offerings
Exhibits155: F. Hoffmann La Roche Ltd. - Overview
Exhibits156: F. Hoffmann La Roche Ltd. - Business segments
Exhibits157: F. Hoffmann La Roche Ltd. - Key news
Exhibits158: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits159: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits160: Ipsen Pharma - Overview
Exhibits161: Ipsen Pharma - Business segments
Exhibits162: Ipsen Pharma - Key offerings
Exhibits163: Ipsen Pharma - Segment focus
Exhibits164: Johnson and Johnson Services Inc. - Overview
Exhibits165: Johnson and Johnson Services Inc. - Business segments
Exhibits166: Johnson and Johnson Services Inc. - Key news
Exhibits167: Johnson and Johnson Services Inc. - Key offerings
Exhibits168: Johnson and Johnson Services Inc. - Segment focus
Exhibits169: LGM Pharma LLC - Overview
Exhibits170: LGM Pharma LLC - Product / Service
Exhibits171: LGM Pharma LLC - Key offerings
Exhibits172: Novartis AG - Overview
Exhibits173: Novartis AG - Business segments
Exhibits174: Novartis AG - Key offerings
Exhibits175: Novartis AG - Segment focus
Exhibits176: Novo Nordisk AS - Overview
Exhibits177: Novo Nordisk AS - Business segments
Exhibits178: Novo Nordisk AS - Key offerings
Exhibits179: Novo Nordisk AS - Segment focus
Exhibits180: Pfizer Inc. - Overview
Exhibits181: Pfizer Inc. - Product / Service
Exhibits182: Pfizer Inc. - Key news
Exhibits183: Pfizer Inc. - Key offerings
Exhibits184: Sanofi SA - Overview
Exhibits185: Sanofi SA - Business segments
Exhibits186: Sanofi SA - Key news
Exhibits187: Sanofi SA - Key offerings
Exhibits188: Sanofi SA - Segment focus
Exhibits189: Inclusions checklist
Exhibits190: Exclusions checklist
Exhibits191: Currency conversion rates for US$
Exhibits192: Research methodology
Exhibits193: Validation techniques employed for market sizing
Exhibits194: Information sources
Exhibits195: List of abbreviations